RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Food4, In the Aug 21 press release they said they were planning to appeal the decision, and request a hearing before the qualifications listing panel. The hearing is anticipated to be scheduled within 45 days of the hearing request.

So it sounds like this appeals process probably takes longer than our timeframe for the partnership deal or MA, plus a partnership would presumably prompt another re-evaluation due to the cash infusion Cortex would receive. And of course in the case of a MA/buyout, the delisting outcome wouldn't matter either way.